home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Referral

 
  July 25, 2013  
     
 
ComplianceOnline, Online Event
2013-08-06


Why Should You Attend:

New medicines are developed every day to meet medical needs and improve quality of life. Analytical procedures are used to establish acceptance criteria and monitor quality of drug products. Therefore, validation becomes a critical process especially with the changes throughout the drug development process. It is important to understand validation requirements set forth by ICH and GMPs.

This webinar will present the common deficiencies in relation to method validation, outline regulatory requirements and the change control process needed to stay in compliance.

Learning Objectives:

Upon completion of this session, attendees will understand cGMP and ICH validation requirements for analytical procedures and learn key factors that would affect validation process of analytical procedures. It would help scientists to develop process to evaluation method validation, review changes, and determine when re-validation would need to take place. It will discuss observations and infractions related to method validation.

Areas Covered in the Webinar:

  • Deficiencies related to Method Validation.
  • Factors affecting Quality of Medicines.
  • Validation Characteristics
  • Validation vs Re-Validation plan
  • Tracking record of validation project.
  • Change control of validation

Who will Benefit:

  • Senior management in pharmaceutical analysis
  • Pharmaceutical scientists
  • Analysts and lab managers
  • QA managers and personnel
  • Regulatory affairs
  • Contract research laboratories
 
 
Organized by: ComplianceOnline
Invited Speakers: Kim Huynh-Ba, has almost 25 years of experience in analytical development, project management, strategic drug development and stability sciences. She currently is the Executive Director of Pharmalytik, where she provides consulting and training services to pharmaceutical companies, including companies operating under FDA’s Consent Decree on harmonization and optimization of analytical best practices since 2003. Her clients are from various sizes of pharmaceutical companies in US and abroad.
 
Deadline for Abstracts: 2013-08-06
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=703041?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.